Guardant Health
GH
#1154
Rank
ยฃ14.94 B
Marketcap
ยฃ110.44
Share price
1.30%
Change (1 day)
51.93%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

Guardant Health (GH) - Net assets

Net assets on the balance sheet as of June 2026 : -ยฃ0.17 Billion

According to Guardant Health 's latest financial reports the company has -ยฃ0.17 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Guardant Health - Net assets on balance sheet (from 2017 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$-ยฃ73.74 Million-33.74%
2024-12-31$-ยฃ0.12 Billion-189.34%
2023-12-31$ยฃ0.12 B150.39%
2022-12-31$ยฃ49.74 M-89.59%
2021-12-31$ยฃ0.47 B-51.95%
2020-12-31$ยฃ0.99 B53.79%
2019-12-31$ยฃ0.64 B56.37%
2018-12-31$ยฃ0.41 B81.11%
2017-12-31$ยฃ0.22 B253.53%
2016-12-31$ยฃ64.58 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Neogen
NEOG
ยฃ1.58 B-1,036.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
ยฃ1.38 B-917.30%๐Ÿ‡บ๐Ÿ‡ธ USA